A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids

American Journal of the Medical Sciences

Volumn 331, Issue 5, 2006, Pages 280-283

  Matsumura, Takayoshi ^b   Matsumoto, Akihiro ^a   Ohno, Minoru ^b   Suzuki, Shinya ^b   Ohta, Miki ^b   Suzuki, Etsu ^b   Takenaka, Katsu ^b   Hirata, Yasunobu ^b   Fujita, Toshiro ^b   Nagai, Ryozo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Blue toe syndrome; Cholesterol; Embolism; Skin biopsy; Statins; Steroids

Indexed keywords

ATORVASTATIN; CANDESARTAN; CHOLESTEROL; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISOLONE; SIMVASTATIN; STEROID; WARFARIN;

AGED; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CASE REPORT; CHOLESTEROL EMBOLISM; CRYSTAL STRUCTURE; DRUG EFFICACY; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; MALE; SKIN BIOPSY; SYSTEMIC DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; BIOPSY; BLUE TOE SYNDROME; DIAGNOSIS, DIFFERENTIAL; EMBOLISM, CHOLESTEROL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PREDNISOLONE; PYRROLES; SIMVASTATIN; SKIN; SKIN DISEASES, VASCULAR; STEROIDS;

EID: 33744503410     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200605000-00010     Document Type: Article

References (13)

1. Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000;36:1089-109.
2. Dupont PJ, Lightstone L, Clutterbuck EJ, et al. Cholesterol emboli syndrome. BMJ 2000;321:1065-7.
3. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999;33:840-50.
4. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003;42:211-6.
5. Bruns FJ, Segel DP, Adler S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci 1978;275:105-8.
6. Badawi G, Jebara VA, Rassi IE, et al. Spontaneous cholesterol embolism: a rarely reported entitiy. Texas Heart Institute J 1994;21:228-30.
7. Ferrari E, Taillan B, Drai E, et al. Investigation of the thoracic aorta in cholesterol embolism by transesophageal echocardiography. Heart 1998;79:133-6.
8. Yonemura K, Ikegaya N, Fujigaki Y, et al. Potential therapeutic effect of simvastatin on progressive renal failure and nephrotic-range proteinuria caused by renal cholesterol embolism. Am J Med Sci 2001;322:50-2.
9. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998;351:1331-2.
10. Fabbian F, Catalano C, Lambertini D, et al. A possible role of corticosteroids in cholesterol crystal embolization. Nephron 1999;83:189-90.
11. Stabellini N, Rizzioli E, Trapassi MR, et al. Renal cholesterol microembolism: is steroid therapy effective? Nephron 2000;86:239-40.
12. Kato A, Ohtsuji A, Terada T, et al. Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism. Nephron 2002;92:240-3.
13. Rumpf KW, Schult S, Mueller GA. Simvastatin treatment in cholesterol emboli syndrome. Lancet 1998;352:321-2.